0001562180-21-000933.txt : 20210205 0001562180-21-000933.hdr.sgml : 20210205 20210205162219 ACCESSION NUMBER: 0001562180-21-000933 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210203 FILED AS OF DATE: 20210205 DATE AS OF CHANGE: 20210205 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Karydas Daphne CENTRAL INDEX KEY: 0001816952 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37708 FILM NUMBER: 21595705 MAIL ADDRESS: STREET 1: 35 GATEHOUSE DRIVE STREET 2: BUILDING D, FLOOR 3 CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Syndax Pharmaceuticals Inc CENTRAL INDEX KEY: 0001395937 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 320162505 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 GATEHOUSE DRIVE STREET 2: BUILDING D, FLOOR 3 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 781-419-1400 MAIL ADDRESS: STREET 1: 35 GATEHOUSE DRIVE STREET 2: BUILDING D, FLOOR 3 CITY: WALTHAM STATE: MA ZIP: 02451 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2021-02-03 false 0001395937 Syndax Pharmaceuticals Inc SNDX 0001816952 Karydas Daphne 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 false true false false Chief Financial Officer Stock Option (Right to Buy) 21.36 2021-02-03 4 A false 95000.00 0.00 A 2031-02-03 Common Stock 95000.00 95000.00 D 1/48th of the shares subject to the option shall vest monthly over a four-year period. /s/ Michael A. Metzger, Attorney-in-Fact 2021-02-05